GNRH AGONIST VERSUS HCG TO INDUCE FINAL OOCYTE MATURATION IN PATIENTS AT LOW RISK OF OHSS

被引：0
|
作者：
Green, K. A. [1 ]
Healy, M. W. [1 ,2 ]
DeCherney, A. H. [1 ]
Beall, A. S. [3 ]
Chang, F. E. [3 ]
Devine, K. [3 ]
Hill, M. J. [1 ,2 ]
机构：
[1] NICHHD, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA
[2] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
[3] Shady Grove Fertil, Rockville, MD USA
来源：
FERTILITY AND STERILITY | 2018年 / 109卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2018.02.055
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-25
引用
收藏
页码：E28 / E28
页数：1
相关论文
共 50 条
  • [31] Minimum dose of hCG to trigger final oocyte maturation and prevent OHSS in a long GnRHa protocol
    Chen, Xin
    Chen, Shi-ling
    He, Yu-xia
    Ye, De-sheng
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (01) : 133 - 136
  • [32] Minimum Dose of hCG to Trigger Final Oocyte Maturation and Prevent OHSS in a Long GnRHa Protocol
    陈薪
    陈士岭
    何于夏
    叶德盛
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2013, 33 (01) : 133 - 136
  • [33] Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study
    Griesinger, G.
    von Otte, S.
    Schroer, A.
    Ludwig, A. K.
    Diedrich, K.
    Al-Hasani, S.
    Schultze-Mosgau, A.
    HUMAN REPRODUCTION, 2007, 22 (05) : 1348 - 1352
  • [34] GnRH agonist for final oocyte maturation trigger and hCG as exclusive luteal support in normal responders, a prospective observational study
    Baram, S.
    Weiss, A.
    Geslevich, Y.
    Beck-Fruchter, R.
    HUMAN REPRODUCTION, 2017, 32 : 303 - 304
  • [35] GNRH AGONIST WITH LOW-DOSE HCG CO-TRIGGER IS ASSOCIATED WITH HIGHER RISK OF SEVERE OHSS THAN GNRH AGONIST ALONE.
    O'Neill, K.
    Senapati, S.
    Maina, I.
    Gracia, C.
    Dokras, A.
    FERTILITY AND STERILITY, 2014, 102 (03) : E7 - E7
  • [36] Luteal phase supplementation at GnRH agonist triggering for final oocyte maturation in GnRH antagonist cycle
    Ozornek, H.
    Ozay, A.
    Ergin, E. G.
    HUMAN REPRODUCTION, 2012, 27
  • [37] A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
    Kolibianakis, EM
    Schultze-Mosgau, A
    Schroer, A
    van Steirteghem, A
    Devroey, P
    Diedrich, K
    Griesinger, G
    HUMAN REPRODUCTION, 2005, 20 (10) : 2887 - 2892
  • [38] GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data
    Kolibianakis, E. M.
    Griesinger, G.
    Venetis, C. A.
    HUMAN REPRODUCTION UPDATE, 2012, 18 (02) : 228 - 229
  • [39] EFFICACY OF AGONIST TRIGGERING AND LOW DOSE HCG IN HIGH RISK OHSS PATIENTS.
    Guivarc'h-Leveque, A.
    Jaffre, F.
    Homer, L.
    Moy, L.
    Colleu, D.
    Arvis, P.
    FERTILITY AND STERILITY, 2013, 100 (03) : S265 - S265
  • [40] GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial
    Yan, Meng-Han
    Cao, Jing-Xian
    Hou, Jin-Wei
    Jiang, Wen-Jing
    Wang, Dan-Dan
    Sun, Zhen-Gao
    Song, Jing-Yan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345